Bioqube Ventures
Uilstraat 30
3500 Hasselt
BE
Bioqube Ventures
Foundation date
21/01/2016
Sector
#InvestorSubsector
Bioqube ventures is a specialist life sciences investment firm that focuses on early-stage investments. We cut cost, accelerate business and bring value by linking three key components: access to capital, specialized infrastructure and expertise. Our partnership with Johnson & Johnson Innovation – JLINX, is the embodiment of our mission: a multifaceted approach that enables early-stage healthcare companies to reach their full potential in a cost effective and time efficient way.
Upcoming events
All events-
1012 '24
Next-Generation Synthetic Biology
Event by: VIB -
0312 '24
BioFIT 2024
Event by: Eurasanté -
0204 '25
The Franco-Belgian Agrifood Summit
Event by: CCI France - Belgique
Latest news
More news-
Bio Base Europe Pilot Plant successfully commissions a 75,000 L fermenter, demonstrating Vivici’s Vivitein™ BLG technology in industrial-scale precision fermentation
21 hours ago
Read more
-
argenx Advances Clinical Development of Efgartigimod SC in Idiopathic Inflammatory Myopathies
Wednesday November 20th 2024
Read more
-
ExeVir Announces Michael Garrett as New Chief Executive Officer
Tuesday November 19th 2024
Read more
Jobs
More jobs-
-
22/11/24
Flemish Brabant
ERC-funded postdoctoral position on engineering gut bacteria for live biotherapeutic applications
Permanent
VIB -
More info?
Ellen Telleir
Communication Coordinator